Gross Margin
19.31%vs Specialty Chemicals peers Updated Aug 19, 2026Profit Margin
-73.99%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
-45.72%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
-1.97%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
-13.91%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
85.00BKRW60.18M · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
1.38KKRWUpdated Aug 19, 2026Quarterly Revenue Growth
-50.60%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
16.24BKRW11.50M · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
-16.82BKRW-11.91M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
-62.89BKRW-44.53M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
-50.59%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
-8.96BKRW-6.35M · vs all stocks (USD) Updated Aug 19, 20265-Year Average Dividend Yield
2.97%Updated Aug 19, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 19, 2026Minority Interest (Equity)
1.79BKRWFY2025 · Dec 31, 2025Revenue
102.78BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
83.54BKRWFY2025 · Dec 31, 2025Gross Profit
19.24BKRWFY2025 · Dec 31, 2025Operating Income
-44.66BKRW-31.62M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-63.00BKRWFY2025 · Dec 31, 2025Income Tax Expense
6.04BKRWFY2025 · Dec 31, 2025Net Income
-69.04BKRWFY2025 · Dec 31, 2025EBIT
-57.56BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
-35.21BKRWFY2025 · Dec 31, 2025Research & Development
15.60BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
18.04BKRWFY2025 · Dec 31, 2025Other Operating Expenses
847.61MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
139.18MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
5.44BKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
-69.04BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
3.24BKRWFY2025 · Dec 31, 2025Operating Cash Flow
-54.08BKRWFY2025 · Dec 31, 2025Free Cash Flow
-67.48BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
6.29BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-69.04BKRWFY2025 · Dec 31, 2025Stock-based Compensation
-253.84MKRWFY2025 · Dec 31, 2025Other Non-cash Items
5.75BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
33.07BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-23.62BKRWFY2025 · Dec 31, 2025Capital Expenditures
-13.39BKRWFY2025 · Dec 31, 2025Purchase of Investments
-439.74MKRWFY2025 · Dec 31, 2025Sale of Investments
2.02BKRWFY2025 · Dec 31, 2025Other Investing Activity
-2.18BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-14.00BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
3.40BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-6.14BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
1.92BKRWFY2025 · Dec 31, 2025Other Financing Charges
-10.00KRWFY2025 · Dec 31, 2025Net Financing Cash Flow
39.47BKRWFY2025 · Dec 31, 2025